SRC and breast cancer: However, the D2 mutant, which lacked the 330–719 fragment of BC, enhanced E‐cadherin and IMPAD1 expression, whereas it reduced Slug expression and Src Y416 and PDPK S241 phosphorylation, which was completely different from the effects of intact BC (Figure S5E).